World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
114
Citations
53187
World Ranking
4696
National Ranking
147

Overview

Rodolfo Montironi is affiliated with Marche Polytechnic University in Italy and has contributed extensively to the field of medicine, with a primary focus on urologic oncology and related disciplines. Their research spans multiple subfields including pulmonary and respiratory medicine, surgery, oncology, rheumatology, and molecular biology.

Montironi's work covers several main topics: prostate cancer treatment and research, prostate cancer diagnosis and treatment, bladder and urothelial cancer treatments, urinary and genital oncology studies, urologic and reproductive health conditions, renal cell carcinoma treatment, and cancer immunotherapy and biomarkers.

Their recent notable publications include:

  • "Epidemiology of Renal Cell Carcinoma: 2022 Update" (2022), published in European Urology
  • "Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer" (2021), published in Cancers
  • "The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer" (2020), published in Archives of Pathology & Laboratory Medicine
  • "Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications" (2020), published in Cells
  • "Epigenetic modulations and lineage plasticity in advanced prostate cancer" (2020), published in Annals of Oncology

Frequent coauthors collaborating with Montironi include:

  • Alessia Cimadamore
  • Liang Cheng
  • Antonio López-Beltrán
  • Matteo Santoni
  • Marina Scarpelli

Their research is frequently published in venues such as:

  • European Urology
  • Cancers
  • European Urology Oncology
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • Translational Andrology and Urology

Montironi's scholarly production includes a substantial number of publications-over 580 across the core field of medicine. Their contributions to urologic oncology have involved both clinical and molecular perspectives, reflecting a multidisciplinary approach.

Their publication topics underline a comprehensive engagement with various urologic cancers and treatment modalities, including diagnostic frameworks and immunotherapy advances. The diversity of their frequent coauthors indicates extensive collaborative networks, contributing to the dissemination and development of knowledge within the specialty of urology and oncology.

Best Publications

  • Bladder cancer: Epidemiology, staging and grading, and diagnosis

    Ziya Kirkali;Theresa Chan;Murugesan Manoharan;Ferran Algaba

  • The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia

    John R. Srigley;Brett Delahunt;John N. Eble;Lars Egevad

  • 2004 WHO Classification of the Renal Tumors of the Adults

    Antonio Lopez-Beltran;Marina Scarpelli;Rodolfo Montironi;Ziya Kirkali

  • EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent

    Kexin Xu;Zhenhua Jeremy Wu;Anna C. Groner;Housheng Hansen He

  • The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters

    Brett Delahunt;John C. Cheville;Guido Martignoni;Peter A. Humphrey

  • Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers

    Gladell P. Paner;Walter M. Stadler;Donna E. Hansel;Rodolfo Montironi

  • The controversial relationship between benign prostatic hyperplasia and prostate cancer: The role of inflammation

    Cosimo De Nunzio;Gero Kramer;Michael Marberger;Rodolfo Montironi

  • Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).

    Valeria Panebianco;Yoshifumi Narumi;Ersan Altun;Bernard H. Bochner

  • Her-2-neu Expression and Progression Toward Androgen Independence in Human Prostate Cancer

    Sabina Signoretti;Rodolfo Montironi;Judith Manola;Annalisa Altimari

  • Prognostic Factors in Prostate Cancer

    David G. Bostwick;David J. Grignon;M. Elizabeth H. Hammond;Mahul B. Amin

  • Extended and Saturation Prostatic Biopsy in the Diagnosis and Characterisation of Prostate Cancer: A Critical Analysis of the Literature

    Vincenzo Scattoni;Alexandre Zlotta;Rodolfo Montironi;Claude Schulman

  • Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine.

    Liang Cheng;Antonio Lopez-Beltran;Francesco Massari;Gregory T MacLennan

  • Positive Surgical Margins After Radical Prostatectomy: A Systematic Review and Contemporary Update

    Ofer Yossepowitch;Alberto Briganti;James A. Eastham;Jonathan Epstein

  • The role of focal therapy in the management of localised prostate cancer: a systematic review

    Massimo Valerio;Massimo Valerio;Hashim U Ahmed;Mark Emberton;Nathan L Lawrentschuk

  • PD-1 blockade therapy in renal cell carcinoma: current studies and future promises.

    F Massari;M Santoni;C Ciccarese;D Santini

  • International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins

    Puay Hoon Tan;Liang Cheng;John R Srigley;David Griffiths

  • The Contemporary Concept of Significant Versus Insignificant Prostate Cancer

    Guillaume Ploussard;Jonathan I. Epstein;Rodolfo Montironi;Rodolfo Montironi;Peter R. Carroll

  • Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.

    Jonathan I. Epstein;Mahul Amin;Liliane Boccon-Gibod;Lars Egevad

  • The 2004 WHO Classification of Bladder Tumors: A Summary and Commentary:

    Rodolfo Montironi;Antonio Lopez-Beltran

  • Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level.

    Theodoros Karantanos;Christopher P. Evans;Bertrand Tombal;Timothy C. Thompson

Frequent Co-Authors

Antonio Lopez-Beltran
Antonio Lopez-Beltran University of Córdoba
Liang Cheng
Liang Cheng Brown University
Gregory T. MacLennan
Gregory T. MacLennan Case Western Reserve University
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University
Lars Egevad
Lars Egevad Karolinska Institute
Jonathan I. Epstein
Jonathan I. Epstein Johns Hopkins University
Stefano Cascinu
Stefano Cascinu Vita-Salute San Raffaele University
David G. Bostwick
David G. Bostwick Bostwick Laboratories
Puay Hoon Tan
Puay Hoon Tan Duke NUS Graduate Medical School
Mahul B. Amin
Mahul B. Amin University of Tennessee Health Science Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in medicine doesn't always start or end with an MD. A variety of online degrees and career pathways open doors in healthcare, offering flexible, accredited options for different interests and schedules.

Those interested in diet and wellness can consider an online BS in nutrition, which equips graduates for roles in public health, hospitals, or private practice. Healthcare administration is another fast-growing field; a CAHME accredited online MHA program prepares future leaders to manage hospitals and healthcare organizations.

For registered nurses, advancing their education is more accessible than ever. Some pursue the RN to BSN without clinicals pathway, allowing for academic advancement with a flexible online curriculum. Meanwhile, those aiming for the highest levels of clinical practice may opt for shortest DNP programs online to achieve a Doctor of Nursing Practice degree with accelerated options.

Whether supporting patients directly or shaping healthcare systems, these online programs offer valuable, accredited ways to advance your career in medicine-related fields.

Best Scientists Citing Rodolfo Montironi

Trending Scientists